[go: up one dir, main page]

AU2003273247A1 - Non-invasive methods to identify agents for treating pain - Google Patents

Non-invasive methods to identify agents for treating pain

Info

Publication number
AU2003273247A1
AU2003273247A1 AU2003273247A AU2003273247A AU2003273247A1 AU 2003273247 A1 AU2003273247 A1 AU 2003273247A1 AU 2003273247 A AU2003273247 A AU 2003273247A AU 2003273247 A AU2003273247 A AU 2003273247A AU 2003273247 A1 AU2003273247 A1 AU 2003273247A1
Authority
AU
Australia
Prior art keywords
treating pain
identify agents
invasive methods
invasive
identify
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003273247A
Other versions
AU2003273247A8 (en
Inventor
Kenneth M. Hargreaves
Karl Keiser
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Texas System
Original Assignee
University of Texas System
University of Texas at Austin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Texas System, University of Texas at Austin filed Critical University of Texas System
Publication of AU2003273247A8 publication Critical patent/AU2003273247A8/en
Publication of AU2003273247A1 publication Critical patent/AU2003273247A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082—Supracellular entities, e.g. tissue, organisms
    • G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/9486—Analgesics, e.g. opiates, aspirine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2003273247A 2002-08-30 2003-08-27 Non-invasive methods to identify agents for treating pain Abandoned AU2003273247A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US40702502P 2002-08-30 2002-08-30
US60/407,025 2002-08-30
PCT/US2003/026890 WO2004019875A2 (en) 2002-08-30 2003-08-27 Non-invasive methods to identify agents for treating pain

Publications (2)

Publication Number Publication Date
AU2003273247A8 AU2003273247A8 (en) 2004-03-19
AU2003273247A1 true AU2003273247A1 (en) 2004-03-19

Family

ID=31978408

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003273247A Abandoned AU2003273247A1 (en) 2002-08-30 2003-08-27 Non-invasive methods to identify agents for treating pain

Country Status (2)

Country Link
AU (1) AU2003273247A1 (en)
WO (1) WO2004019875A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070093420A1 (en) 2005-08-26 2007-04-26 Yeomans David C Therapy procedure for drug delivery for trigeminal pain
HRP20231438T1 (en) 2015-01-07 2024-06-07 Tonix Pharma Limited Magnesium-containing oxytocin formulations and methods of use
JP7093559B2 (en) 2016-04-12 2022-06-30 トライジェミナ， インコーポレイテッド Magnesium-containing oxytocin preparation and method of use
CN120092752A (en) * 2025-05-09 2025-06-06 北京大学人民医院 Trigeminal neuralgia animal model and its construction method and application

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5683725A (en) * 1995-05-25 1997-11-04 Biofrontiers, Inc. Modulation of substance P by compounds containing calcium sulfate and methods relating thereto
ES2277920T3 (en) * 2000-04-07 2007-08-01 Bayer Healthcare Ag TWIK-8 HUMAN MOLECULES AND USES OF THE SAME.

Also Published As

Publication number Publication date
AU2003273247A8 (en) 2004-03-19
WO2004019875A2 (en) 2004-03-11
WO2004019875A3 (en) 2006-07-27

Similar Documents

Publication Publication Date Title
IL172418A0 (en) Therapeutic agents useful for treating pain
AU2003239568A1 (en) Pyrrolotriazinone compounds and their use to treat diseases
IL209352A0 (en) 4-tetrazolyl-4phenylpiperidine derivatives for treating pain
AU2003259249A1 (en) Pyridazinylpiperazine derivatives for treating pain
AU2003286567A8 (en) Methods for the treatment of skin disorders
GB0201850D0 (en) Therapeutic treatment
GB0216321D0 (en) Therapeutic treatment
AU2003300791A1 (en) Combination therapy for the treatment of pain
AU2003283257A1 (en) Scalp treatment
GB0223367D0 (en) Therapeutic treatment
EP1648399A4 (en) Method and topical composition for the treatment of hyperpigmented skin
GB0213869D0 (en) The treatment of pain
PL375584A1 (en) Therapeutic treatment
GB0211295D0 (en) Treatment of pain
AU2003251407A8 (en) Topical treatment for skin irritation
AU2003273247A1 (en) Non-invasive methods to identify agents for treating pain
AU2003255843A1 (en) 1,3-thiazolin-4-ones as therapeutic compounds in the treatment of pain
AU2003275433A1 (en) Compositions and methods for treating pain
GB0311815D0 (en) Skin treatments
GB0221712D0 (en) Methods of treatment
GB0311816D0 (en) Skin treatments
GB0211297D0 (en) Pain treatment
AU2003213349A1 (en) Therapeutic agent for pain
HK1091715A (en) Therapeutic agents useful for treating pain
GB2432322B (en) Gel for tissue treatment

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase